The U.S. Drug Testing & Approval Process (2013 MDF Annual Conference)
Dr. Doug Kerr, M.D., Ph.D., of Biogen-Idec, describes the U.S. process for taking a drug from testing to approval.
Dr. Doug Kerr, M.D., Ph.D., of Biogen-Idec, describes the U.S. process for taking a drug from testing to approval.
People living with myotonic dystrophy have a frank discussion about the biggest challenges facing their lives.